Literature DB >> 3016392

Surgical clinicopathologic study of malignant fibrous histiocytoma.

T Tsumori, K Nakao, M Miyata, T Hashimoto, K Nakahara, M Kim, K Kuwata, M Sakurai, Y Kawashima.   

Abstract

Fifteen men and six women, ranging in age from 20 to 79 years, with malignant fibrous histiocytoma comprised this series. Amputation of the right lower extremity was performed in one patient, wide resection in 7 and marginal excision in 9, respectively. In the other 4 patients, a non-curative resection was carried out. Adjuvant chemotherapy was prescribed post-operatively for 12 patients. Histologic grade of the surgical specimens was Stage I in 3, II in 6, III in 8 and IV in 4. Among fourteen patients living from 10 months to 9 years and 9 months after the operation, the 7 subjected to a wide resection are all disease free. Seven patients died of a local recurrence or a distant metastases. The survival rate of the patients with Stages I, II is significantly higher than those with Stages III, IV. These results show that a wide resection is to be favored and that staging is useful to estimate the prognosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016392     DOI: 10.1007/bf02471094

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  13 in total

1.  MALIGNANT FIBROUS XANTHOMAS.

Authors:  J E O'BRIEN; A P STOUT
Journal:  Cancer       Date:  1964-11       Impact factor: 6.860

2.  [Malignant fibrous histiocytoma: a clinicopathologic study of 130 cases (author's transl)].

Authors:  H Hashimoto
Journal:  Fukuoka Igaku Zasshi       Date:  1979-10

3.  A clinical and pathological staging system for soft tissue sarcomas.

Authors:  W O Russell; J Cohen; F Enzinger; S I Hajdu; H Heise; R G Martin; W Meissner; W T Miller; R L Schmitz; H D Suit
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

4.  Chemotherapy of malignant fibrous histiocytoma: a Southwest Oncology Group report.

Authors:  C Leite; J W Goodwin; J G Sinkovics; L H Baker; R Benjamen
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

5.  Fibroxanthosarcoma of the soft tissues. A type of malignant fibrous histiocytoma.

Authors:  R L Kempson; M Kyriakos
Journal:  Cancer       Date:  1972-04       Impact factor: 6.860

6.  Chemotherapy in complex treatment of bone and soft tissue sarcomas.

Authors:  Z Matĕjovský
Journal:  Oncology       Date:  1980       Impact factor: 2.935

7.  Primary malignant fibrous histiocytoma of bone.

Authors:  S S Spanier; W F Enneking; P Enriquez
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

8.  Experimental approach to fibrous histiocytoma.

Authors:  T Yumoto; K Morimoto
Journal:  Acta Pathol Jpn       Date:  1980-09

9.  Malignant fibrous histiocytoma. A clinicopathologic study of 130 cases.

Authors:  M Enjoji; H Hashimoto; M Tsuneyoshi; H Iwasaki
Journal:  Acta Pathol Jpn       Date:  1980-09

10.  Chemotherapy of patients with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophosphamide (DAC).

Authors:  J Brenner; G B Magill; P Wissel; P P Sordillo
Journal:  Cancer       Date:  1983-10-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.